Ustekinumab Works Well in Ulcerative Colitis in the General Population
NEW YORK (Reuters Health) – The monoclonal antibody ustekinumab (Stelara, Janssen) appears to be at least as effective against ulcerative
Read more
NEW YORK (Reuters Health) – The monoclonal antibody ustekinumab (Stelara, Janssen) appears to be at least as effective against ulcerative
Read more